4
Changes in Ownership
Traws Pharma, Inc. Filed Acc 0002018150-26-000002
Options or other derivatives
- Chief Science Officer Virology acquired 118,367 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Pauza Charles David Chief Science Officer Virology | 2026-03-08 | Grant or award · Stock Option (right to buy) | +118,367 | 118,367 | D: show line 1 in the form |
Loading xslF345X05/form4-03102026_110321.xml…